Athavale A U, More N P, More N N, Chajed P, Gandewar K, Shah A C
Department of Respiratory Diseases, LTMG Hospital, Sion, Bombay.
J Indian Med Assoc. 1997 Jan;95(1):12-3.
Present day management of bronchial asthma focuses on use of inhaled drugs. To find out the acceptability of aerosol therapy at primary care level, a questionnaire survey was conducted on practical acceptance of aerosol therapy in management of asthma. Seven clinically relevant questions were asked regarding management modalities followed in bronchial asthma. Amongst the group of general practitioners (n = 60) studied, it was found that in treatment of chronic stable asthma inhaled steroids are used by only 50% and inhaled bronchodilators by 86.7%, whereas 93.3% use oral bronchodilators and 60% use oral steroids to treat the same. During exacerbation injectable bronchodilators are preferred to inhaled drugs. Poor compliance to aerosol therapy was reported by 33.3%. Reasons for non-compliance are discussed, important ones are cost and technique. Spacer was reported to be useful by 20% and lung functions are carried out occasionally by only 5% of practitioners.
当今支气管哮喘的治疗重点在于使用吸入药物。为了了解基层医疗水平下雾化治疗的可接受性,针对哮喘管理中雾化治疗的实际接受情况进行了问卷调查。就支气管哮喘的治疗方式提出了七个临床相关问题。在所研究的全科医生群体(n = 60)中,发现治疗慢性稳定哮喘时,仅50%的医生使用吸入性类固醇,86.7%的医生使用吸入性支气管扩张剂,而93.3%的医生使用口服支气管扩张剂,60%的医生使用口服类固醇来治疗相同病症。在病情加重期间,注射用支气管扩张剂比吸入药物更受青睐。据报告,33.3%的人对雾化治疗依从性差。讨论了不依从的原因,重要原因是成本和技术。据报告,20%的人认为储雾罐有用,只有5%的医生偶尔进行肺功能检查。